MedTrace Logo

Kidney Function in Sickle Cell Anemia

NCT03277547 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-01-27

No results posted yet for this study

Summary

This is a prospective clinical cohort study that involves a baseline study visit followed by up to 3 annual follow-up study visits for a total follow-up of 36-48 months to evaluate the age- and sex-adjusted rate of change in kidney function, and to identify biomarkers of endothelial function, metabolomic profiles and clinical characteristics for the worsening of kidney function and for a rapid decline in kidney function.

"Funding Source - FDA OOPD"

Conditions

Sponsors & Collaborators

  • Ohio State University

    collaborator OTHER

  • University of North Carolina

    collaborator OTHER

  • Kenneth Ataga MD

    lead OTHER

Principal Investigators

  • Kenneth Ataga, MD · UTHSC Center for Sickle Cell Disease

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-17
Primary Completion
2025-06-01
Completion
2025-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03277547 on ClinicalTrials.gov